Valeant Chief Executive Officer Mike Pearson To Give Deposition To Senate Committee Investigating Drug Pricing

Michael "Mike" Pearson, chairman and chief executive officer of Valeant Pharmaceuticals International Inc., exits a a Senate Committee on Rules and Administration office in Washington, D.C., U.S., on Monday, April 18, 2016. The committee is deposing Pearson in private before an April 27 hearing in Washington where he is scheduled to testify. Pearson had originally failed to comply with a subpoena to be deposed and changed course after the committee threatened to hold him in contempt. Photographer: Drew Angerer/Bloomberg via Getty Images
Michael "Mike" Pearson, chairman and chief executive officer of Valeant Pharmaceuticals International Inc., exits a a Senate Committee on Rules and Administration office in Washington, D.C., U.S., on Monday, April 18, 2016. The committee is deposing Pearson in private before an April 27 hearing in Washington where he is scheduled to testify. Pearson had originally failed to comply with a subpoena to be deposed and changed course after the committee threatened to hold him in contempt. Photographer: Drew Angerer/Bloomberg via Getty Images
Valeant Chief Executive Officer Mike Pearson To Give Deposition To Senate Committee Investigating Drug Pricing
KÖP EN LICENS
Hur får jag använda den här bilden?
kr 4,200.00
SEK

INFORMATION

Begränsningar:
Kontakta ditt lokala kontor för all kommersiell eller marknadsföringsrelaterad användning.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
Upphovsman:
Bloomberg / Contributor
Redaktionell fil nr:
522340084
Samling:
Bloomberg
Datum skapat:
18 april 2016
Uppladdningsdatum:
Releaseinformation:
Saknar release. Mer information
Källa:
Bloomberg
Objektnamn:
PEARSON VALEANT
Högsta tillåtna filstorlek:
4355 x 2903 bpkt (36,87 x 24,58 cm) - 300 dpi - 5 MB